Development of a hemostatic wound dressing incorporating lyophilized platelets

Award Information
Agency:
Department of Defense
Branch
Army
Amount:
$750,000.00
Award Year:
2005
Program:
SBIR
Phase:
Phase II
Contract:
W81XWH-05-C-0057
Agency Tracking Number:
O2-0347
Solicitation Year:
2004
Solicitation Topic Code:
OSD04-H17
Solicitation Number:
2004.3
Small Business Information
ADLYFE INC.
9430 Key West Avenue, Suite 210, Rockville, MD, 20850
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
137192840
Principal Investigator:
David Ho
Director of Hematology
(301) 424-8344
dho@adlyfe.com
Business Contact:
Richard Cliff
COO
(301) 424-8344
rcliff@adlyfe.com
Research Institution:
n/a
Abstract
Blood loss due to uncontrolled hemorrhage is a major contribution to at least 90% of the combat death before reaching the field hospital. The ability to control heavy bleeding in the injured soldier is critical and will vastly improve the survival outcome in the theater. Furthermore, complications from uncontrolled bleeding in the microvasculature contribute significantly to increased morbidity. Finally, disruption of the vasculature during trauma can limit healing and soft tissue repair and regenerative phases once bleeding has subsided. Our goal is to address these critical aspects of combat casualty care, providing first echelon care that will have significant impact on acute events as well as improved outcome late into the time course of treatment and recovery. Our approach to developing next generation hemostatic products for combat casualty care is to exploit the natural properties of platelets which contain both hemostatic and healing properties.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government